June 16, 2008

Boston Business Journal

Acceleron expanding, adding jobs

Acceleron Pharma Inc. is expanding its protein-manufacturing capabilities and will beef up employment to fill a variety of jobs throughout the company.The Cambridge, Mass.-based company, which is developing treatments to modulate the growth of bone and muscle tissue, said Monday that it plans to add as many as 40 additional employees to its 85-person staff through the end of this year.Acceleron has leased an additional 37,500 square feet of space, which doubles its existing administrative, laboratory and manufacturing space in Cambridge.The new space is expected to house the company's second manufacturing facility for Growth and Differentiation Factors-related proteins.The privately held company expects to launch two midstage human clinical trials later this year for ACE-011, a bone forming agent designed to reverse bone loss in diseases such as cancer.Two new programs will also reach clinical trials by the end of the year, including a treatment to increase skeletal muscle mass and strength, and a drug to block blood vessel maturation.